HealthPartners Institute
healthpartners.comLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
164
Active
23
Phase 3
2
Total enrollment
273,827
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Sotagliflozin initiation | — | — | — | — | — | 1 | |
| Medical Cannabis | — | — | — | — | — | 1 | |
| axelopran | — | — | — | — | — | 1 | |
| Regular Insulin | — | — | — | — | — | 1 | |
| Indocyanine Green Angiogram | — | — | — | — | — | 1 | |
| Lecanemab | — | — | — | — | — | 1 |
Next readouts
- 2025-02-01
- 2026-08
- 2026-09
- 2027-11-01
- 2027-12-31
- 2028-05
Top conditions
- Type 2 Diabetes12
- Hypertension12
- Diabetes8
- Obesity6
- Hyperlipidemia5
- Diabetes Mellitus5
- Breast Cancer5
- Dementia5
Frequently asked questions about HealthPartners Institute
- How many clinical trials does HealthPartners Institute have on ClinicalTrials.gov?
- HealthPartners Institute is listed as the lead sponsor on 164 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
- How many of HealthPartners Institute's trials are in Phase 3?
- 2 of HealthPartners Institute's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does HealthPartners Institute focus on?
- HealthPartners Institute's most-studied conditions on ClinicalTrials.gov are Type 2 Diabetes, Hypertension, Diabetes, Obesity, Hyperlipidemia.
- When are HealthPartners Institute's next clinical trial readouts?
- HealthPartners Institute has 6 upcoming primary-completion readouts tracked here; the soonest is “Comparison of ICG Microangiography and Conventional Angiography in Severe Frostbite”, expected around 2025-02-01.